Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 33 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2005RANK expression in normal and malignant cells: a monoclonal antibody studyKostakis, P.; Atkins, G.; Vincent, C.; Farrugia, A.; Findlay, D.; Evdokiou, A.; Zannettino, A.; Annual Meeting of the American Society for Bone and Mineral Research (27th : 2005 : Nashville, Tennessee)
2002Zoledronate is anabolic for human osteoblast-like cellsAtkins, G.; Pan, B.; Findlay, D.; To, L.; Evdokiou, A.; Labrinidis, A.; Bouralexis, S.; Zannettino, A.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2000Expression of osteoclast differentiation signals by stromal elements of giant cell tumorsAtkins, G.; Haynes, D.; Graves, S.; Evdokiou, A.; Hay, S.; Bouralexis, S.; Findlay, D.
2000Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cellsKitahama, S.; Gibson, M.; Hatzinikolas, G.; Hay, S.; Kuliwaba, J.; Evdokiou, A.; Atkins, G.; Findlay, D.
2013Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse modelsLuo, K.; Ko, C.; Yue, G.; Lee, M.; Siu, W.; Lee, J.; Shum, W.; Fung, K.; Leung, P.; Li, G.; Evdokiou, A.; Lau, C.
2006The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILButler, L.; Liapis, V.; Bouralexis, S.; Welldon, K.; Hay, S.; Thai, L.; Labrinidis, A.; Tilley, W.; Findlay, D.; Evdokiou, A.
2000Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptorRaggatt, L.; Evdokiou, A.; Findlay, D.
2010Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat modelLabrinidis, A.; Hay, S.; Liapis, V.; Findlay, D.; Evdokiou, A.
2005Death to the bad buys: Targeting cancer via Apo2L/TRAILBouralexis, S.; Findlay, D.; Evdokiou, A.
2005Synergistic induction of prostate cancer cell death by g-tocotrienol and lovastatin is mediated by direct geranylgeranyl pyrophosphate inhibition through a caspase-independent pathwayOdysseos, A.; Vraka, P.; Liapis, V.; Hay, S.; Evdokiou, A.